Csaba Farsang

Active 1979–2024

19
Papers
33,225
Citations
18
h-index
18
i10-index

Citations

Citations per year for Csaba Farsang1981: 3 citations1982: 8 citations1983: 10 citations1984: 6 citations1985: 3 citations1986: 5 citations1988: 6 citations1989: 2 citations1990: 1 citations1991: 1 citations1993: 3 citations1994: 5 citations1996: 2 citations1997: 1 citations2000: 1 citations2001: 2 citations2002: 1 citations2003: 15 citations2004: 54 citations2005: 114 citations2006: 111 citations2007: 150 citations2008: 131 citations2009: 157 citations2010: 145 citations2011: 132 citations2012: 192 citations2013: 189 citations2014: 164 citations2015: 166 citations2016: 149 citations2017: 141 citations2018: 153 citations2019: 929 citations2020: 1,042 citations2021: 910 citations2022: 516 citations2023: 393 citations2024: 559 citations2025: 196 citations2026: 12 citations1987: no citations, so this year is not shown1992: no citations, so this year is not shown1995: no citations, so this year is not shown1998–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,668 citing papers, 13.2% of this breakdownItaly: 1,049 citing papers, 8.3% of this breakdownUnited Kingdom: 931 citing papers, 7.4% of this breakdownChina: 741 citing papers, 5.9% of this breakdownGermany: 640 citing papers, 5.1% of this breakdownSpain: 497 citing papers, 3.9% of this breakdownFrance: 413 citing papers, 3.3% of this breakdownAustralia: 403 citing papers, 3.2% of this breakdownNetherlands: 400 citing papers, 3.2% of this breakdownJapan: 364 citing papers, 2.9% of this breakdownGreece: 322 citing papers, 2.6% of this breakdownSweden: 302 citing papers, 2.4% of this breakdown
0%13.2%Other 38.6%

Fields

  • Medicine86.9%
  • Biochemistry, Genetics and Molecular Biology3.3%
  • Nursing1.9%
  • Health Professions1.6%
  • Engineering1.1%
  • Neuroscience1%
  • Other4.2%

Topics

  • Blood Pressure and Hypertension Studies14.5%
  • Cardiovascular Health and Disease Prevention5.5%
  • Sodium Intake and Health4.3%
  • Heart Rate Variability and Autonomic Control3.7%
  • Diabetes Treatment and Management2.5%
  • Hormonal Regulation and Hypertension2.3%
  • Other67.2%

Coauthors

All papers

Open in search
  1. 2018 ESC/ESH Guidelines for the management of arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anthony M. Heagerty, Stefan Agewall, Murielle Bochud, Claudio Borghi, Pierre Boutouyrie, Jana Brguljan, Héctor Bueno, Enrico G. Caiani, Bo Carlberg, Neil Chapman, Renata Cífková, John G.F. Cleland, Jean-Philippe Collet, Ioan Mircea Coman, Peter W. de Leeuw, Victoria Delgado, Paul Dendale, Hans‐Christoph Diener, Maria Dorobanţu, Robert Fagard, Csaba Farsang, Marc Ferrini, Ian M Graham, Guıdo Grassı, Hermann Haller, F D Richard Hobbs, Bojan Jelakovic, Catriona Jennings, Hugo A Katus, Abraham A Kroon, Christophe Leclercq, Dragan Lovic, Empar Lurbe, Athanasios Manolis, Theresa A McDonagh, Franz H. Messerli, María Lorenza Muiesan, Uwe Nixdorff, Michael Hecht Olsen, Gianfranco Parati, Joep Perk, Massimo Francesco Piepoli, Jorge Polonia, Piotr Ponikowski, Dimitrios J Richter, Stefano F. Rimoldi, Marco Roffi, Naveed Sattar, Petar Seferovic, Iain A Simpson, Miguel Sousa-Uva, Alice Stanton, Philippe van de Borne, Panos E. Vardas, Massimo Volpe, Sven Waßmann, Stephan Windecker, Jose Luis Zamorano, Stephan Windecker, Victor Aboyans, Stefan Agewall, Emanuele Barbato, Héctor Bueno, António Coca, Jean-Philippe Collet, Ioan Mircea Coman, Verónica Dean, Victoria Delgado, Donna Fitzsimons, O. Gaemperli and 111 more - European Heart Journal 2018 cited by 10,433

  2. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Enrique Romero Bobillo, Carmen de la Cuesta, Csaba Farsang, Albert Császár, Barbara Zahorska‐Markiewicz, Danuta Pupek-Musialik, Edward Franek, Lucyna Ostrowska, Magdalena Olszanecka‐Glinianowicz, Nebojša Lalić, Dragan Micić, Bernhard Ludvik, Bernhard Paulweber, Rudolf Prager, André Scheen, Luc Van Gaal, Arne Astrup, Kjeld Hermansen, Sten Madsbad, Aila Rissanen, Sakari Nieminen, Markku J. Savolainen, Michel Krempf, Monique Romon, M. Laville, Michel Marre, R Mira, Francis Finucane, Aletha Veenendaal, Frank van Berkum, Solrun Johannsson-Vidarsdóttir, V. Van de Walle, Eelco W. Meesters, Jøran Hjelmesæth, Tor Ole Klemsdal, Bård Kulseng, Birgit Bach-Kliegel, Kurt Laederach, Lukas Villiger, Alain Golay, Stefan Bilz, Thozhukat Sathyapalan, Stephen C. Bain, Sudhesh Kumar, Carel Wynard le Roux, Michael E. J. Lean, Barbara McGowan, Michael E.J. Lean, John Wilding, Gary Wittert, Ian Caterson, Joeseph Proietto, John Prins, Bruno Geloneze Neto, Jorge Luiz Gross, Antônio Roberto Chacra, Alfredo Halpern, Henrique Suplicy, Francis Chun Chung Chow, Hemant Thacker, Manoj Chadha, Hemaraj Chandalia, AG Unnikrishnan, Sanjay Kalra, Neeta Deshpande, Minakshi Shunmugavelu, Vaishali Deshmukh, Maximo Maislos, G. Lieberman, Ilan Shimon and 104 more - The Lancet 2017 cited by 844

  3. 2013 ESH/ESC Guidelines for the management of arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margus Viigimaa, Ettore Ambrosioni, Mark Caufield, António Coca, Michael Hecht Olsen, Roland E Schmieder, Costas Tsioufis, Philippe van de Borne, Jose Luis Zamorano, Stephan Achenbach, Helmut Baumgartner, Jeroen J. Bax, Héctor Bueno, Veronica Dean, Christi Deaton, Çetin Erol, Robert Fagard, Roberto Ferrari, David Hasdai, Arno W Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Patrizio Lancellotti, Aleš Linhart, Petros Nihoyannopoulos, Massimo Piepoli, Piotr Ponikowski, Per Anton Sirnes, Juan Tamargo, Michał Tendera, Adam Torbicki, William Wijns, Stephan Windecker, Denis Clément, António Coca, Thierry Gillebert, Michał Tendera, Enrico Agabiti Rosei, Ettore Ambrosioni, Stefan D Anker, Johann Bauersachs, Jana Brguljan Hitij, Mark J. Caulfield, Marc De Buyzere, Sabina De Geest, Geneviève Dérumeaux, Serap Erdine, Csaba Farsang, Christian Funck‐Brentano, Vjekoslav Gerc, Giuseppe Germanò, Stephan Gielen, Herman Haller, Arno W Hoes, Jens Jordan, Thomas Kahan, Michel Komajda, Dragan Lović, Heiko Mahrholdt, Michael Hecht Olsen, Jan Östergren, Gianfranco Parati, Joep Perk, Jorge Polónia, Bogdan A Popescu, Zeljko Reiner, Lars Rydén, Yu.M. Sіrenko, Alice Stanton and 6 more - European Heart Journal 2013 cited by 13,677

  4. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. Widimsky, José Luis Zamorano, SE Kjeldsen, Serap Erdine, Krzysztof Narkiewicz, W. Kiowski, Enrico Agabiti‐Rosei, E Ambrosioni, Renata Cífková, Anna F. Dominiczak, R. Fagard, A. M. Heagerty, S. Laurent, Lars Lindholm, G. Mancia, Athanasios Manolis, Peter M. Nilsson, Josep Redón, Roland E. Schmieder, Harry A.J. Struijker-Boudier, Margus Viigimaa, Document Reviewers:, G. Filippatos, Stamatis Adamopoulos, Enrico Agabiti‐Rosei, E Ambrosioni, Vicente Bertoméu, D Clément, Serap Erdine, Csaba Farsang, D. Gaita, W. Kiowski, Gregory Y.H. Lip, Jean-Michel Mallion, Athanasios Manolis, Peter M. Nilsson, Eoin O’Brien, Piotr Ponikowski, Josep Redón, Frank Ruschitzka, Juan Tamargo, PA van Zwieten, Margus Viigimaa, Bernard Waeber, Bryan Williams, José Luis Zamorano - European Heart Journal 2006 cited by 2,388

  5. Non-invasive assessment of microvascular endothelial function by laser doppler flowmetry in patients with essential hypertension

    Authors: , , , , - Atherosclerosis 2004 cited by 123

  6. Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: A substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration

    Authors: , , , , , , , , , - American Heart Journal 2007 cited by 100

  7. 2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - 2003 cited by 2,605

  8. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margus Viigimaa, Alberto Zanchetti - Blood Pressure 2009 cited by 1,656

  9. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.

    Authors: , , , , , , , , , , , , , , , , , - 2003 cited by 299

  10. β-Endorphin: Possible Involvement in the Antihypertensive Effect of Central α-Receptor Activation

    Authors: , , - Science 1981 cited by 164

  11. NALOXONE REVERSES THE ANTIHYPERTENSIVE EFFECT OF CLONIDINE

    Authors: , - British Journal of Pharmacology 1979 cited by 155

  12. Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study

    Authors: , , , , , , , , , , , , - European Heart Journal 2010 cited by 87

  13. Effect of single-pill versus free equivalent combinations on persistence and major adverse cardiovascular events in hypertension: a real-world analysis

    Authors: , , , , , , , , - Journal of Hypertension 2024 cited by 9

  14. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension

    Authors: , , , , , , , , - Journal of the American College of Cardiology 2004 cited by 180

  15. Possible role of an endogenous opiate in the cardiovascular effects of central alpha adrenoceptor stimulation in spontaneously hypertensive rats.

    Authors: , , , - Journal of Pharmacology and Experimental Therapeutics 1980 cited by 146

  16. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey

    Authors: , , , , - Journal of Hypertension 2008 cited by 106

  17. Effect of Valsartan Added to Background ACE Inhibitor Therapy in Patients with Heart Failure: Results from Val-HeFT

    Authors: , , , , , , , - European Journal of Heart Failure 2004 cited by 98

  18. Reversal by naloxone of the antihypertensive action of clonidine: involvement of the sympathetic nervous system.

    Authors: , , , , , , - Circulation 1984 cited by 80

  19. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roland E. Schmieder, Michel Burnier, Maciej Banach, Renata Cífková, Csaba Farsang, А. О. Конради, I. Lazareva, Yu.M. Sіrenko, Maria Dorobanţu, Arman Postadzhiyan, Rok Accetto, Bojan Jelaković, Dragan Lović, Athanasios Manolis, Philippos Stylianou, Serap Erdine, Dror Dicker, Gangzhi Wei, Chengbin Xu, Hengge Xie, António Coca, John T. O’Brien, Gary A. Ford - Journal of Hypertension 2014 cited by 75

All 19 papers shown.